Funding Rounds
SciRhom Series A (2024, $68M)
SciRhomiRhom2 antibodies developer for better treatment of autoimmune diseases.
Summary
Stage: Series A
Raised Amount: $68.25M
Raised Date: 2024-09-01
Stage: Series A
Raised Amount: $68.25M
Raised Date: 2024-09-01